Device Week, 21 January 2021 – EY M&A Firepower, JPM and NANS events highlights, CorWave Profile

Citeline Podcasts

English - January 21, 2021 22:39 - 12 minutes - 12.7 MB - ★★★★★ - 24 ratings
Business News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Scrip’s Five Must-Know Things – 18 January 2021

Next Episode: Scrip’s Five Must-Know Things – 25 January 2021

In this week’s podcast, Medtech Insight's managing editor Marion Webb and deputy editor Reed Miller discuss highlights from the recent J.P. Morgan Healthcare and North American Neuromodulation Society (NANS) virtual meetings. London, UK-based reporter Barnaby Pickering profiles start-up CorWave SA, which developed a left ventricular assist device for treating end-stage heart failure.

Listen to the podcast via the player below:

NANS 2021: Nevro’s HF10 Spinal-Cord Stimulator Succeeds In Two Trials

NANS 2021: Boston Scientific Advances New Personalized Pain Therapy

JPM 2021: EY Says Pandemic Leaves Medtech With $500Bn In M&A Firepower

Start-Up Spotlight: CorWave Takes Inspiration From Nature To Tackle Heart Failure

JPM 2021: Conformis Announces ACS Knee For 2H 2021, Integra Weathers Pandemic

JPM 2021: Intuitive Surgical, Accelerate Diagnostics, Siemens Healthineers, Exact Sciences, Renalytix

JPM 2021: Boston Scientific, Abbott, Dexcom, Insulet, Silk Road Medical

JPM 2021: Medtronic, Biogen, Edwards LifeSciences, Guardant Health, Illumina

For more information on Medtech Insight and to start a free trial, click here:
http://bit.ly/2w7LnlR

Medtech Insight articles addressing topics discussed in this episode: